| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10172111 | Respiratory Investigation | 2014 | 8 Pages |
Abstract
In NSCLC patients treated by chemotherapy for recurrence, preoperative measurements of 18F-FDG uptake may be a more powerful surrogate marker for predicting outcome when measured preoperatively at the primary tumor site rather than postoperatively at sites of recurrence.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Kyoichi Kaira, Nobuyuki Yamamoto, Hirotsugu Kenmotsu, Haruyasu Murakami, Akira Ono, Tateaki Naito, Masahiro Endo, Toshiaki Takahashi,